Serum Carboxy-terminal Cross-linking Telopeptide Fragments of Type-2 Collagen Level in the General Population: A Pilot Study

Author:

Khanna Rajat1,Jindal Divyam1,Singh Sudhir1

Affiliation:

1. Department of Orthopaedics, Teerthanker Mahaveer Medical College and Research Centre, Moradabad, Uttar Pradesh, India

Abstract

Abstract Aim: The aim of this study was to determine the serum carboxy-terminal cross-linking telopeptide fragments of type-2 collagen (sCTX-II) level in normal healthy young and middle-aged individuals. Materials and Methods: Normal healthy adults were included as the participants in this study (175 participants). The age, gender, weight, and height of individuals were recorded. Venous samples (5 ml) were collected for the estimation of the sCTX-II level by ELISA kit. Results: The mean sCTX-II level was recorded as 400.42 ± 208.08 pg/ml. The mean sCTX-II level among males was recorded as 406.49 ± 220.79 pg/ml, and in females, it was 382.34 ± 157.88 pg/ml), and the difference is not statistically significant (P = 0.50). The sCTX-II value was recorded as 389.11 ± 199.79 pg/ml in the age group of 19–29 years, 430.45 ± 231.71 pg/ml in the age group of 30–39 years, and 424.12 ± 223.35 pg/ml in the age group of 40–49 years; however, this difference was not statistically significant (P = 0.524). The CTX-II value in the underweight category was 365.55 ± 197.09 pg/ml; in the normal body mass index (BMI) category, it was 404.58 ± 225.29 pg/ml; in the overweight category, the BMI was 392.99 ± 193.79 pg/ml; and in obese BMI category, the value was 417.32 ± 186.79 pg/ml. Our results revealed that the sCTX-II level is independent of age (F = 0.64, P = 0.524), gender (t = 0.66, P = 0.50), and BMI (F = 0.15, P = 0.92). Conclusion: We concluded that the sCTX-II level does not get affected by age, gender, and BMI in the general population. The sCTX-II estimation can be used to differentiate the cases of knee osteoarthritis from the normal population as it is independent of age, gender, and BMI. The sCTX-II value in young and middle-aged healthy populations is reported. However, a multicentric study with stringent subject selection criteria is needed to corroborate the results of this pilot study.

Publisher

Medknow

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3